Low‐and middle‐income countries (LMIC) face unique challenges with regard to the
establishment of robust pharmacovigilance systems capable of generating data to inform …

Introduction As patient and public involvement (PPI) in research has become increasingly
common, research‐based recommendations on its principles and impacts have been …

Abstract Objectives The Joint ISPOR-ISPE Special Task Force on Real-World Evidence
included patient/stakeholder engagement as a recommended good procedural practice …

Purposes The aim of the pharmacovigilance (PV) process is to bring together all the much‐
needed information about various aspects of product safety or, in particular, the safety and …

Among people who use drugs, individual drug use characteristics and outcomes vary
widely. For many, no adverse health events will occur nor will they seek healthcare for drug …

Background and aims There is increasing recognition of the importance of patient
involvement in research. In recent years, there has also been growing interest in patient …

Background Public involvement enhances the relevance, quality, and impact of research.
There is some evidence that public involvement in Australian research lags other countries …

Regulatory agencies are increasingly considering real‐world evidence (RWE) to support
label expansions of approved medicines. We conducted a comparative effectiveness study …

Purpose Rigorously conducted pharmacoepidemiologic research requires methodologically
complex study designs and analysis yet evaluates problems of high importance to patients …

ABSTRACT Most sub-Sahara African countries faced with prolonged resource deficiencies
suffers specific constraints in establishing a functional and operationally-free …